UFP Technologies, Inc. (NASDAQ: UFPT) Stock Competitors & Peer Comparison
See UFPT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for UFPT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| UFPT | $300.05 | +0.03% | 2.3B | 30.65 | $9.79 | N/A |
| ABT | $112.47 | +0.79% | 194.6B | 21.58 | $5.21 | +2.21% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $330.69 | +2.66% | 126.8B | 24.70 | $13.39 | +1.05% |
| MDT | $91.23 | +1.40% | 116.7B | 16.49 | $5.53 | +3.12% |
| BSX | $46.84 | +0.36% | 69.6B | 15.11 | $3.10 | N/A |
| EW | $90.21 | +0.29% | 51.9B | 33.41 | $2.70 | N/A |
| DXCM | $90.82 | +1.71% | 34.3B | 35.62 | $2.55 | N/A |
| GEHC | $71.72 | -1.05% | 32.4B | 15.73 | $4.56 | +0.19% |
| PHG | $26.72 | -0.74% | 26.1B | 15.26 | $1.75 | +3.71% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
UFPT vs ABT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ABT has a market cap of 194.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ABT trades at $112.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ABT's P/E ratio is 21.58. In terms of profitability, UFPT's ROE is +0.17%, compared to ABT's ROE of +0.11%. Regarding short-term risk, UFPT is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
UFPT vs BSX-PA Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, UFPT's ROE is +0.17%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, UFPT is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
UFPT vs SYK Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SYK has a market cap of 126.8B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SYK trades at $330.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SYK's P/E ratio is 24.70. In terms of profitability, UFPT's ROE is +0.17%, compared to SYK's ROE of +0.16%. Regarding short-term risk, UFPT is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check SYK's competition here
Medtronic plc (NYSE: MDT)
UFPT vs MDT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, MDT has a market cap of 116.7B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while MDT trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas MDT's P/E ratio is 16.49. In terms of profitability, UFPT's ROE is +0.17%, compared to MDT's ROE of +0.10%. Regarding short-term risk, UFPT is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
UFPT vs BSX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BSX has a market cap of 69.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BSX trades at $46.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BSX's P/E ratio is 15.11. In terms of profitability, UFPT's ROE is +0.17%, compared to BSX's ROE of +0.15%. Regarding short-term risk, UFPT is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
UFPT vs EW Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, EW has a market cap of 51.9B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while EW trades at $90.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas EW's P/E ratio is 33.41. In terms of profitability, UFPT's ROE is +0.17%, compared to EW's ROE of +0.10%. Regarding short-term risk, UFPT is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
UFPT vs DXCM Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, DXCM has a market cap of 34.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while DXCM trades at $90.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas DXCM's P/E ratio is 35.62. In terms of profitability, UFPT's ROE is +0.17%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, UFPT is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
UFPT vs GEHC Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, GEHC has a market cap of 32.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while GEHC trades at $71.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas GEHC's P/E ratio is 15.73. In terms of profitability, UFPT's ROE is +0.17%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, UFPT is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
UFPT vs PHG Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PHG trades at $26.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PHG's P/E ratio is 15.26. In terms of profitability, UFPT's ROE is +0.17%, compared to PHG's ROE of +0.10%. Regarding short-term risk, UFPT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
UFPT vs ZBH Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ZBH has a market cap of 19.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ZBH trades at $100.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ZBH's P/E ratio is 11.90. In terms of profitability, UFPT's ROE is +0.17%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, UFPT is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
UFPT vs ABMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ABMD's P/E ratio is 65.36. In terms of profitability, UFPT's ROE is +0.17%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, UFPT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
UFPT vs PEN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PEN trades at $321.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PEN's P/E ratio is 84.03. In terms of profitability, UFPT's ROE is +0.17%, compared to PEN's ROE of +0.11%. Regarding short-term risk, UFPT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
UFPT vs SWAV Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SWAV's P/E ratio is 78.76. In terms of profitability, UFPT's ROE is +0.17%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, UFPT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
UFPT vs SNN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SNN has a market cap of 12.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SNN trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SNN's P/E ratio is 13.64. In terms of profitability, UFPT's ROE is +0.17%, compared to SNN's ROE of +0.12%. Regarding short-term risk, UFPT is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
UFPT vs ALGN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ALGN has a market cap of 11.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ALGN trades at $157.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ALGN's P/E ratio is 14.36. In terms of profitability, UFPT's ROE is +0.17%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, UFPT is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
UFPT vs GMED Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, GMED has a market cap of 11.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while GMED trades at $82.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas GMED's P/E ratio is 18.69. In terms of profitability, UFPT's ROE is +0.17%, compared to GMED's ROE of +0.12%. Regarding short-term risk, UFPT is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
UFPT vs GKOS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while GKOS trades at $179.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas GKOS's P/E ratio is -209.16. In terms of profitability, UFPT's ROE is +0.17%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, UFPT is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
UFPT vs BIO-B Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BIO-B has a market cap of 10.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BIO-B trades at $387.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BIO-B's P/E ratio is -68.15. In terms of profitability, UFPT's ROE is +0.17%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, UFPT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
UFPT vs BIO Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BIO trades at $387.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BIO's P/E ratio is 41.79. In terms of profitability, UFPT's ROE is +0.17%, compared to BIO's ROE of +0.03%. Regarding short-term risk, UFPT is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
UFPT vs PODD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PODD trades at $145.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PODD's P/E ratio is 24.72. In terms of profitability, UFPT's ROE is +0.17%, compared to PODD's ROE of +0.27%. Regarding short-term risk, UFPT is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
UFPT vs MASI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas MASI's P/E ratio is 44.43. In terms of profitability, UFPT's ROE is +0.17%, compared to MASI's ROE of +0.09%. Regarding short-term risk, UFPT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
UFPT vs BRKR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BRKR has a market cap of 8.7B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BRKR trades at $57.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BRKR's P/E ratio is 28.68. In terms of profitability, UFPT's ROE is +0.17%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, UFPT is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
UFPT vs BRKRP Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BRKRP has a market cap of 8.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BRKRP trades at $420.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BRKRP's P/E ratio is 229.28. In terms of profitability, UFPT's ROE is +0.17%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, UFPT is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
UFPT vs HAE Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while HAE trades at $103.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas HAE's P/E ratio is 20.74. In terms of profitability, UFPT's ROE is +0.17%, compared to HAE's ROE of +0.11%. Regarding short-term risk, UFPT is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
UFPT vs NARI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NARI's P/E ratio is -59.24. In terms of profitability, UFPT's ROE is +0.17%, compared to NARI's ROE of -0.00%. Regarding short-term risk, UFPT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
UFPT vs LIVN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while LIVN trades at $80.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas LIVN's P/E ratio is 19.08. In terms of profitability, UFPT's ROE is +0.17%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, UFPT is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
UFPT vs ITGR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ITGR trades at $125.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ITGR's P/E ratio is 19.73. In terms of profitability, UFPT's ROE is +0.17%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, UFPT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
UFPT vs IRTC Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while IRTC trades at $120.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas IRTC's P/E ratio is -270.53. In terms of profitability, UFPT's ROE is +0.17%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, UFPT is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
UFPT vs AXNX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AXNX's P/E ratio is -709.80. In terms of profitability, UFPT's ROE is +0.17%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, UFPT is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
UFPT vs TMDX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while TMDX trades at $88.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas TMDX's P/E ratio is 44.89. In terms of profitability, UFPT's ROE is +0.17%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, UFPT is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
UFPT vs AXGN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AXGN has a market cap of 2.8B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AXGN trades at $51.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AXGN's P/E ratio is 135.45. In terms of profitability, UFPT's ROE is +0.17%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, UFPT is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
UFPT vs NEOG Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NEOG trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NEOG's P/E ratio is 41.64. In terms of profitability, UFPT's ROE is +0.17%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, UFPT is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
UFPT vs BFLY Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BFLY has a market cap of 2.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BFLY trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BFLY's P/E ratio is -35.12. In terms of profitability, UFPT's ROE is +0.17%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, UFPT is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
UFPT vs NUVA Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NUVA's P/E ratio is 75.00. In terms of profitability, UFPT's ROE is +0.17%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, UFPT is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
UFPT vs ESTA Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ESTA trades at $70.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ESTA's P/E ratio is -56.06. In terms of profitability, UFPT's ROE is +0.17%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, UFPT is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
UFPT vs NVCR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NVCR trades at $17.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NVCR's P/E ratio is -13.71. In terms of profitability, UFPT's ROE is +0.17%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, UFPT is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
UFPT vs INSP Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while INSP trades at $61.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas INSP's P/E ratio is 27.10. In terms of profitability, UFPT's ROE is +0.17%, compared to INSP's ROE of +0.18%. Regarding short-term risk, UFPT is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
UFPT vs CNMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CNMD trades at $49.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CNMD's P/E ratio is 11.00. In terms of profitability, UFPT's ROE is +0.17%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, UFPT is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CNMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
UFPT vs TNDM Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while TNDM trades at $21.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas TNDM's P/E ratio is -23.04. In terms of profitability, UFPT's ROE is +0.17%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, UFPT is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
UFPT vs ATEC Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ATEC trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ATEC's P/E ratio is -157.33. In terms of profitability, UFPT's ROE is +0.17%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, UFPT is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check ATEC's competition here
Enovis Corporation (NYSE: ENOV)
UFPT vs ENOV Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ENOV has a market cap of 1.4B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ENOV trades at $24.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ENOV's P/E ratio is 7.13. In terms of profitability, UFPT's ROE is +0.17%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, UFPT is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
UFPT vs IART Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while IART trades at $16.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas IART's P/E ratio is 7.16. In terms of profitability, UFPT's ROE is +0.17%, compared to IART's ROE of -0.01%. Regarding short-term risk, UFPT is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check IART's competition here
Heska Corporation (NASDAQ: HSKA)
UFPT vs HSKA Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas HSKA's P/E ratio is -62.49. In terms of profitability, UFPT's ROE is +0.17%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, UFPT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check HSKA's competition here
Artivion, Inc. (NYSE: AORT)
UFPT vs AORT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AORT trades at $26.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AORT's P/E ratio is 44.57. In terms of profitability, UFPT's ROE is +0.17%, compared to AORT's ROE of -0.01%. Regarding short-term risk, UFPT is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check AORT's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
UFPT vs PRCT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PRCT trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PRCT's P/E ratio is -10.74. In terms of profitability, UFPT's ROE is +0.17%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, UFPT is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
UFPT vs AVNS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AVNS's P/E ratio is 27.77. In terms of profitability, UFPT's ROE is +0.17%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, UFPT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
UFPT vs SILK Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SILK's P/E ratio is -18.96. In terms of profitability, UFPT's ROE is +0.17%, compared to SILK's ROE of -0.35%. Regarding short-term risk, UFPT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
UFPT vs IRMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while IRMD trades at $87.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas IRMD's P/E ratio is 43.75. In terms of profitability, UFPT's ROE is +0.17%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, UFPT is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check IRMD's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
UFPT vs LMRI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while LMRI trades at $11.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas LMRI's P/E ratio is -22.39. In terms of profitability, UFPT's ROE is +0.17%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, UFPT is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
UFPT vs FNA Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas FNA's P/E ratio is -19.83. In terms of profitability, UFPT's ROE is +0.17%, compared to FNA's ROE of -0.35%. Regarding short-term risk, UFPT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
UFPT vs BVS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BVS has a market cap of 937.6M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BVS trades at $13.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BVS's P/E ratio is 18.21. In terms of profitability, UFPT's ROE is +0.17%, compared to BVS's ROE of +0.28%. Regarding short-term risk, UFPT is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
UFPT vs CBLL Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CBLL has a market cap of 900.4M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CBLL trades at $23.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CBLL's P/E ratio is -13.48. In terms of profitability, UFPT's ROE is +0.17%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, UFPT is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
UFPT vs BBNX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BBNX has a market cap of 887.2M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BBNX trades at $19.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BBNX's P/E ratio is -11.95. In terms of profitability, UFPT's ROE is +0.17%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, UFPT is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
UFPT vs INMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, INMD has a market cap of 853.6M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while INMD trades at $14.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas INMD's P/E ratio is 10.31. In terms of profitability, UFPT's ROE is +0.17%, compared to INMD's ROE of +0.12%. Regarding short-term risk, UFPT is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check INMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
UFPT vs SIBN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SIBN has a market cap of 852M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SIBN trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SIBN's P/E ratio is -56.50. In terms of profitability, UFPT's ROE is +0.17%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, UFPT is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
UFPT vs AVR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AVR has a market cap of 849.8M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AVR trades at $8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AVR's P/E ratio is -4.51. In terms of profitability, UFPT's ROE is +0.17%, compared to AVR's ROE of -0.78%. Regarding short-term risk, UFPT is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
UFPT vs CSII Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CSII's P/E ratio is -20.83. In terms of profitability, UFPT's ROE is +0.17%, compared to CSII's ROE of -0.14%. Regarding short-term risk, UFPT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check CSII's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
UFPT vs AHCO Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, AHCO has a market cap of 787.8M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while AHCO trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas AHCO's P/E ratio is 11.82. In terms of profitability, UFPT's ROE is +0.17%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, UFPT is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check AHCO's competition here
Varex Imaging Corporation (NASDAQ: VREX)
UFPT vs VREX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, VREX has a market cap of 778.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas VREX's P/E ratio is 19.47. In terms of profitability, UFPT's ROE is +0.17%, compared to VREX's ROE of +0.05%. Regarding short-term risk, UFPT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
UFPT vs SSII Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SSII has a market cap of 696.5M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SSII trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SSII's P/E ratio is -67.88. In terms of profitability, UFPT's ROE is +0.17%, compared to SSII's ROE of -0.27%. Regarding short-term risk, UFPT is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
UFPT vs SRDX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SRDX's P/E ratio is -34.66. In terms of profitability, UFPT's ROE is +0.17%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, UFPT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
UFPT vs CTKB Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CTKB has a market cap of 604.4M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CTKB trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CTKB's P/E ratio is -24.79. In terms of profitability, UFPT's ROE is +0.17%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, UFPT is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CTKB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
UFPT vs KIDS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, KIDS has a market cap of 599M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while KIDS trades at $23.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas KIDS's P/E ratio is -19.76. In terms of profitability, UFPT's ROE is +0.17%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, UFPT is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
UFPT vs APEN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas APEN's P/E ratio is -9.43. In terms of profitability, UFPT's ROE is +0.17%, compared to APEN's ROE of -0.85%. Regarding short-term risk, UFPT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
UFPT vs DCTH Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, DCTH has a market cap of 564.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while DCTH trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas DCTH's P/E ratio is 1634.00. In terms of profitability, UFPT's ROE is +0.17%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, UFPT is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
UFPT vs ZIMV Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, UFPT's ROE is +0.17%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, UFPT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
UFPT vs CERS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CERS has a market cap of 534M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CERS trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CERS's P/E ratio is -52.89. In terms of profitability, UFPT's ROE is +0.17%, compared to CERS's ROE of -0.10%. Regarding short-term risk, UFPT is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
UFPT vs TCMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, TCMD has a market cap of 522.4M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while TCMD trades at $23.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas TCMD's P/E ratio is 21.44. In terms of profitability, UFPT's ROE is +0.17%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, UFPT is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
UFPT vs NPCE Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NPCE has a market cap of 491.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NPCE trades at $14.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NPCE's P/E ratio is -25.28. In terms of profitability, UFPT's ROE is +0.17%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, UFPT is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
UFPT vs CLPT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CLPT has a market cap of 466.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CLPT trades at $15.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CLPT's P/E ratio is -13.18. In terms of profitability, UFPT's ROE is +0.17%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, UFPT is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
UFPT vs SGHT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SGHT has a market cap of 465.2M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SGHT trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SGHT's P/E ratio is -15.27. In terms of profitability, UFPT's ROE is +0.17%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, UFPT is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
UFPT vs CARL Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CARL has a market cap of 458.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CARL trades at $16.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CARL's P/E ratio is -11.80. In terms of profitability, UFPT's ROE is +0.17%, compared to CARL's ROE of -0.38%. Regarding short-term risk, UFPT is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
UFPT vs PACB Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PACB has a market cap of 434.8M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PACB trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PACB's P/E ratio is -3.41. In terms of profitability, UFPT's ROE is +0.17%, compared to PACB's ROE of -49.62%. Regarding short-term risk, UFPT is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check PACB's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
UFPT vs OFIX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, OFIX has a market cap of 392.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while OFIX trades at $9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas OFIX's P/E ratio is -6.32. In terms of profitability, UFPT's ROE is +0.17%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, UFPT is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check OFIX's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
UFPT vs SENS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SENS has a market cap of 389.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SENS trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SENS's P/E ratio is -4.18. In terms of profitability, UFPT's ROE is +0.17%, compared to SENS's ROE of -1.66%. Regarding short-term risk, UFPT is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check SENS's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
UFPT vs CATX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CATX has a market cap of 353M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CATX trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CATX's P/E ratio is -2.33. In terms of profitability, UFPT's ROE is +0.17%, compared to CATX's ROE of -0.42%. Regarding short-term risk, UFPT is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
UFPT vs SMLR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas SMLR's P/E ratio is 3.92. In terms of profitability, UFPT's ROE is +0.17%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, UFPT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
UFPT vs TMCI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, TMCI has a market cap of 301.7M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while TMCI trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas TMCI's P/E ratio is -4.95. In terms of profitability, UFPT's ROE is +0.17%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, UFPT is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check TMCI's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
UFPT vs TLSI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, TLSI has a market cap of 297.4M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while TLSI trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas TLSI's P/E ratio is -2.87. In terms of profitability, UFPT's ROE is +0.17%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, UFPT is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
UFPT vs CV Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, CV has a market cap of 296.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while CV trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas CV's P/E ratio is -2.37. In terms of profitability, UFPT's ROE is +0.17%, compared to CV's ROE of -1.78%. Regarding short-term risk, UFPT is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check CV's competition here
RxSight, Inc. (NASDAQ: RXST)
UFPT vs RXST Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, RXST has a market cap of 291.8M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while RXST trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas RXST's P/E ratio is -6.24. In terms of profitability, UFPT's ROE is +0.17%, compared to RXST's ROE of -0.17%. Regarding short-term risk, UFPT is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check RXST's competition here
Avita Medical Inc. (NASDAQ: RCEL)
UFPT vs RCEL Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, RCEL has a market cap of 257.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while RCEL trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas RCEL's P/E ratio is -7.19. In terms of profitability, UFPT's ROE is +0.17%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, UFPT is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check RCEL's competition here
Profound Medical Corp. (NASDAQ: PROF)
UFPT vs PROF Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, PROF has a market cap of 248.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while PROF trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas PROF's P/E ratio is -6.99. In terms of profitability, UFPT's ROE is +0.17%, compared to PROF's ROE of -0.56%. Regarding short-term risk, UFPT is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check PROF's competition here
Electromed, Inc. (AMEX: ELMD)
UFPT vs ELMD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ELMD has a market cap of 245.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ELMD trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ELMD's P/E ratio is 22.61. In terms of profitability, UFPT's ROE is +0.17%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, UFPT is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check ELMD's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
UFPT vs MGRM Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas MGRM's P/E ratio is -12.00. In terms of profitability, UFPT's ROE is +0.17%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, UFPT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check MGRM's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
UFPT vs INFU Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, INFU has a market cap of 242.6M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while INFU trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas INFU's P/E ratio is 29.32. In terms of profitability, UFPT's ROE is +0.17%, compared to INFU's ROE of +0.15%. Regarding short-term risk, UFPT is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check INFU's competition here
Nevro Corp. (NYSE: NVRO)
UFPT vs NVRO Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas NVRO's P/E ratio is -1.91. In terms of profitability, UFPT's ROE is +0.17%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, UFPT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
UFPT vs STIM Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, STIM has a market cap of 204.6M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while STIM trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas STIM's P/E ratio is -6.68. In terms of profitability, UFPT's ROE is +0.17%, compared to STIM's ROE of -1.51%. Regarding short-term risk, UFPT is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
UFPT vs BSGM Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas BSGM's P/E ratio is -5.81. In terms of profitability, UFPT's ROE is +0.17%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, UFPT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
UFPT vs LUCD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, LUCD has a market cap of 189.1M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while LUCD trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas LUCD's P/E ratio is -2.68. In terms of profitability, UFPT's ROE is +0.17%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, UFPT is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
UFPT vs MDGS Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas MDGS's P/E ratio is -0.27. In terms of profitability, UFPT's ROE is +0.17%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, UFPT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
UFPT vs QIPT Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas QIPT's P/E ratio is -15.87. In terms of profitability, UFPT's ROE is +0.17%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, UFPT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
UFPT vs FOCL Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, FOCL has a market cap of 161.5M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while FOCL trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas FOCL's P/E ratio is -4.17. In terms of profitability, UFPT's ROE is +0.17%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, UFPT is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
UFPT vs QSI Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, QSI has a market cap of 154.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while QSI trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas QSI's P/E ratio is -1.70. In terms of profitability, UFPT's ROE is +0.17%, compared to QSI's ROE of -0.47%. Regarding short-term risk, UFPT is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
UFPT vs INGN Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, INGN has a market cap of 148.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while INGN trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas INGN's P/E ratio is -6.04. In terms of profitability, UFPT's ROE is +0.17%, compared to INGN's ROE of -0.13%. Regarding short-term risk, UFPT is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
UFPT vs QTRX Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, QTRX has a market cap of 124.4M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while QTRX trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas QTRX's P/E ratio is -1.04. In terms of profitability, UFPT's ROE is +0.17%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, UFPT is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
UFPT vs ICAD Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas ICAD's P/E ratio is -20.37. In terms of profitability, UFPT's ROE is +0.17%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, UFPT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for UFPT.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
UFPT vs LNSR Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, LNSR has a market cap of 101.9M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while LNSR trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas LNSR's P/E ratio is 8.47. In terms of profitability, UFPT's ROE is +0.17%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, UFPT is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check LNSR's competition here
Pulmonx Corporation (NASDAQ: LUNG)
UFPT vs LUNG Comparison September 2026
UFP Technologies, Inc. (NASDAQ: UFPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UFPT stands at 2.3B. In comparison, LUNG has a market cap of 100.5M. Regarding current trading prices, UFPT is priced at $300.05 on the NASDAQ, while LUNG trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UFPT currently has a P/E ratio of 30.65, whereas LUNG's P/E ratio is -2.05. In terms of profitability, UFPT's ROE is +0.17%, compared to LUNG's ROE of -0.97%. Regarding short-term risk, UFPT is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for UFPT.Check LUNG's competition here